Educational Wellness Information Only
This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.
Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.
GHK-Cu vs Matrixyl (Palmitoyl Pentapeptide-4)
An educational, source-based comparison of GHK-Cu and Matrixyl (Palmitoyl Pentapeptide-4) — how each peptide works, what it's researched for, and what to know before going deeper.
A naturally occurring tripeptide (Glycyl-L-Histidyl-L-Lysine) that forms a complex with copper(II) ions. Research indicates it modulates ~4,000 human genes, downregulating those associated with inflammation and tissue breakdown while upregulating genes tied to collagen synthesis, antioxidant defense, and stem cell activation.
- Collagen and elastin synthesis
- Wound healing
- Hair follicle stimulation
- Skin barrier and antioxidant capacity
- Anti-glycation in dermal fibroblasts
- • Topical formulations have decades of cosmetic safety data; injectable use is less studied.
- • Copper sensitivity is rare but possible.
- • Compounded injectable GHK-Cu is not FDA-approved.
Topical matrikine researched for collagen stimulation.
A signal peptide that mimics the procollagen-I fragment, stimulating fibroblasts to produce collagen, elastin, and glycosaminoglycans in topical cosmetic research.
- Dermal collagen synthesis
- Fine lines and skin firmness
- • Well tolerated in topical use.
- • Modest improvements; not equivalent to retinoids.
Trial-evidence rating
Educational grade reflecting how many peer-reviewed studies and FDA actions we cite for each peptide. Not a clinical recommendation.
Two cited studies; independent replication needed.
Early-stage research; conclusions are tentative.
Study-by-study comparison
| Peptide | Study | Source | Year | Summary |
|---|---|---|---|---|
| GHK-Cu | GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration | BioMed Research International | 2015 | Comprehensive review of GHK-Cu's gene modulation and tissue remodeling effects. |
| GHK-Cu | Resetting skin genome back to health | Cosmetics & Toiletries | 2013 | Documented gene expression changes restoring older skin patterns toward youthful profiles. |
| Matrixyl (Palmitoyl Pentapeptide-4) | Palmitoyl pentapeptide-4 in anti-aging skincare | International Journal of Cosmetic Science | 2005 | Improved wrinkle parameters versus placebo in topical trial. |
Side-effect & safety grid
- Topical formulations have decades of cosmetic safety data; injectable use is less studied.
- Copper sensitivity is rare but possible.
- Compounded injectable GHK-Cu is not FDA-approved.
- Well tolerated in topical use.
- Modest improvements; not equivalent to retinoids.
Educational summary of considerations reported in research literature — not a complete list of adverse events. Discuss with a licensed clinician before any use.
GHK-Cu vs Matrixyl (Palmitoyl Pentapeptide-4) — Key differences
- Class: GHK-Cu is classified as Skin · Regeneration, while Matrixyl (Palmitoyl Pentapeptide-4) is Skin · Collagen.
- Primary research focus: GHK-Cu — collagen and elastin synthesis; Matrixyl (Palmitoyl Pentapeptide-4) — dermal collagen synthesis.
- Tag: Skin · Anti-aging vs Skin.